News
US Biotech Affinivax To Be Bought By GSK For $3.3 billion
In a deal worth up to $3.3 billion, GlaxoSmithKline (GSK) has reached a formal agreement to buy 100% of the outstanding shares of Affinivax, a clinical-stage biopharmaceutical company based in the United States. GSK will make an initial payment...
News
Peli BioThermal Completes Innovation Webinar Series Hosted by Industry Experts
Peli BioThermal, the life science industry’s partner from discovery to distribution, recently concluded its InnovationShare webinar series. Launched in March 2021, InnovationShare was designed to fill the in-person learning gap during the height of the COVID-19 pandemic. Webinars brought...
News
Memo Therapeutics Has Begun BK Virus Therapeutic Experiment
Memo Therapeutics has brought to notice the start of a clinical trial in renal transplant patients to treat BK polyomavirus (BKV) infection.The safety, tolerability, and pharmacokinetics of MTX-005 will be assessed in a phase 1 single-blind, partially randomised, and placebo-controlled...
News
Jubilant Wins $146.6 Mn Contract To Boost Injectables Output
Jubilant HollisterStier has grabbed a $146.6 million contract from the US government, continuing to ride the industrial expansion wave created by the COVID-19 business boom. The contract, which was signed with numerous agencies of the Department of Health and...
News
Sandoz Endorses A Global Campaign To Promote Biosimilars
Sandoz, a biosimilars manufacturer, has announced the beginning of a new global campaign to combat global health disparities. By harnessing the '4 As' of biosimilars- approval, accessibility, acceptability, and affordability, Act4Biosimilars strives to expand patient access to innovative treatments....
News
UK Is First Country Passing Pandemic Preparedness Resolution
After the United Kingdom and Argentina presented a "landmark" decision to the World Health Assembly in Geneva recently, the world took a huge step toward greater pandemic preparedness.
More specific financing will be advocated for within the resolution, allowing developing...
News
The FDA Approves Novartis Follicular Lymphoma Cell Therapy
The US Food and Drug Administration (FDA) has granted Novartis expedited approval for its CAR-T cell therapy Kymriah (tisagenlecleucel) to treat people with relapsed or refractory (r/r) follicular lymphoma (FL) following two or more lines of conventional therapy.
As part...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read